Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma - Poorvi Subramanian; Sreenidhi Mohanvelu; Dinesh Babu Somasundaram; Sheeja Aravindan; Natarajan Aravindan (Cancer Communications)